Evkeeza, a drug developed by Regeneron Pharmaceuticals, received expanded regulatory approvals in Canada and the European Commission.
1 report, 1 independent
Updated Jul 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Evkeeza, a drug developed by Regeneron Pharmaceuticals, received expanded regulatory approvals in Canada and the European Commission.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Regeneron Pharmaceuticals
American pharmaceutical company
Coverage
Newest first; wire copies grouped- Pharmaceutical TechnologyHealth Canada extends Evkeeza approval for children with HoFH Ultragenyx Pharmaceuticals has announced the extension of approval by Health Canada for Evkeeza (evinacumab) as an adjunct to diet and ot